was formed out of the compassion, drive, leadership and dedication
of Maynard Howe, PhD and Roger Howe, PhD, seeking hope for their
sister-in-law, severely injured in an automobile accident in 2004.
Arlene Howe suffered a broken spinal cord and other injuries that
left her quadriplegic and severely compromised her quality of
life and independence. She was unable to walk and needed help
with bathing, dressing, and caring for herself in every way.
To regain as much mobility as possible, Arlene tried many forms of treatment. For fourteen months she went through extensive physical therapy, acupuncture and exercise routines. These approaches resulted in some improvement, although not enough to overcome a heavy dependence on the assistance of caregivers.
After fourteen months, there was nowhere else to go. For Arlene
and for her husband, Ron, the future looked bleak. Arlene had
become what is classically known as a "no option" patient -
someone who has exhausted all traditional forms of medical treatment
and therapy and whose recovery and well being have plateaued
and Roger decided to seek out alternate solutions for Arlene.
Through a trusted colleague, Dr. Nikolai Tankovich, they met
with top Russian scientists, researchers and physicians. The
Howes learned that over 2,000 patients had been treated with
adult stem cells for conditions such as Alzheimer's, Parkinson's,
stroke, diseases of the eye, spinal cord injuries and other
serious medical problems. Their hopes rose from these initial
During this trip, they were able to meet and talk with many of the patients and hear their stories of recovery and improvement. The Howes realized that the adult stem cell treatments and successes in Russia could potentially be used to assist Arlene in regaining functionality and independence.
Arlene was treated with adult stems cells in April 2006. Within
four months, many basic life-functioning abilities began to
return and Arlene was able regain her independence.
After two treatments and extensive rehabilitation, Arlene is
now able to function at a level which allows her to drive her
car and move in and out of her wheelchair and automobile without
assistance. She can also stand on her own and perform many activities,
providing her with a renewed quality of life.
leading entrepreneurs in the medical and technology fields, the
Howe's and their friend Dr. Nikolai Tankovich recognized the potential
of the treatment that Arlene had received to transform the lives
of millions of people facing similar challenges.
They immediately structured a relationship with leading Russian
researchers and physicians so that the technology and research
that had so miraculously helped Arelene - and been used successfully
for decades in Russia - could be successfully transferred to
The Company’s executive team began an extensive due diligence
process on the technology and transplantation methodologies
used in treating these patients.
This due diligence process included:
- extensive translation and review of hundreds of stem cell
related scientific papers and journal articles documenting
30 years of pre-clinical research (animal) and clinical (human)
- interviews with Russian and Ukraine scientists and physicians
who have been treating “no option” patients using stem cell
- interviews with patients and members of their families.
Documents and patient records were examined by Stemedica’s
scientists, physicians and executives, as well as independent
scientific advisors from the United States. In addition, Stemedica
brought several “no option” patients from the United States,
Europe, Asia and the former Soviet Union to Moscow for treatment
To further substantiate the advances achieved in Russia and
the Ukraine, Stemedica established its own laboratory in San
Diego, California, retained a group of leading stem cell scientists
and physicians and began an extensive process of evaluating
the reliability and efficacy, of the science, technology and
protocols for isolating, expanding and possessing stem cells
and the methodologies used to treat patients. Based upon the
successful due diligence and evaluative process, the Company
acquired the trade secrets and intellectual property rights
to this advanced adult stem cell technology, know-how, and treatment
methodologies and officially launched Stemedica. Research and
treatment protocols grounded in nearly 30 years of extensive
adult stem cell studies in both pre-clinical and clinical settings
from the Presidents Kremlin Hospital and the Fedorov, Koltsov
and Helmholtz Institutes in Moscow, Russia, are now a part of
the Stemedica Story.
Stemedica has also secured comprehensive strategic relationships
with the world’s foremost bone and soft tissue regeneration
experts which provides the Company with detailed access to the
most advanced preparation, transplantation and therapy techniques
in these fields. To date, our partners have had successful bone
and soft tissue regeneration experience using adult stem cells,
including scar repair, with over 1,800 patients.
continues its work with Russian researchers and physicians,
as well as dozens of other stem cell experts around the world
to further enhance this proven technology. In order to bring
this breakthrough (change) medical treatment to others around
the world, Stemedica, makes its proprietary adult stem cell
products available through worldwide Licensed Treatment Centers.
These Licensed Treatment Centers
are screened and trained to ensure a comprehensive and successful
approach to patient treatment.
The Howe family experience evolved from a seemingly tragic
event to an opportunity to offer options to people with conditions
for whom traditional therapies and treatments provide no options.
Thanks to the inspiration and courage of Arlene Howe and the
family's dedication in finding a viable treatment alternative,
people who once had limited or no options will now be able to
tap into the power, promise and hope of stem cells.